Author

T. Lenac Rovis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:protein structure· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

A. Decker· 1 shared A. E. Chaouat· 1 shared B. Politi· 1 shared C. Egerer-Sieber· 1 shared D. Wolf· 1 shared E. B. Vitner· 1 shared E. Zahavi· 1 shared G. Roi· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Decker

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The crystal structure of the varicella zoster Orf24-Orf27 nuclear egress complex spotlights multiple determinants of herpesvirus subfamily specificity

J. Schweininger, M. Kriegel, S. Häge, M. Conrad, S. Alkhashrom, J. Lösing, S. Weiler, J. Tillmanns, C. Egerer-Sieber, A. Decker, T. Lenac Rovis, J. Eichler, H. Sticht, M. Marschall, Y. Muller

The paper describes the crystal structure of the VZV Orf24-Orf27 complex, revealing subfamily-specific features that explain differences in NEC interactions across herpesviruses.

bioRxiv · Aug 23, 2021Biochemistry

SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection

A. E. Chaouat, H. Achdout, I. Kol, O. Berhani, G. Roi, E. B. Vitner, S. Melamed, B. Politi, E. Zahavi, I. Brizic, T. Lenac Rovis, O. B. Alfi, D. Wolf, S. Jonjic, T. Israely, O. Mandelboim

This paper develops RBD-Ig fusion proteins that efficiently neutralize SARS-CoV-2 infection in vitro and in vivo, outperforming ACE2-Ig.

bioRxiv · Apr 18, 2021Immunology